论文信息 - CHAMPION-1: a phase 1/2 study of once-weekly carfilzomib and dexamethasone for relapsed or refractory multiple myeloma. - 字舞流文

CHAMPION-1: a phase 1/2 study of once-weekly carfilzomib and dexamethasone for relapsed or refractory multiple myeloma.

R. Moss | R. Rifkin | Y. Ou | A. Cartmell | J. Berenson | M. Coleman | R. Lyons | D. Tzachanis | P. Patel | A. Bessudo | R. Boccia | J. Anderl | J. Berdeja | W. Harb | R. Agajanian | S. Aggarwal | S. Dixon